(Q46617233)

23 December 2017

title

Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study (English)

1 reference

23 December 2017

0 references

0 references

1

A Ghezzi

1 reference

23 December 2017

M P Amato

2

1 reference

23 December 2017

M Capobianco

3

1 reference

23 December 2017

P Gallo

4

1 reference

23 December 2017

G Marrosu

5

1 reference

23 December 2017

V Martinelli

6

1 reference

23 December 2017

N Milani

7

1 reference

23 December 2017

C Milanese

8

1 reference

23 December 2017

L Moiola

9

1 reference

23 December 2017

F Patti

10

1 reference

23 December 2017

V Pilato

11

1 reference

23 December 2017

C Pozzilli

12

1 reference

23 December 2017

M Trojano

13

1 reference

23 December 2017

M Zaffaroni

14

1 reference

23 December 2017

G Comi

15

1 reference

23 December 2017

Immunomodulatory Treatment of Early onset MS Group

16

1 reference

23 December 2017

publication date

1 August 2005

1 reference

23 December 2017

Multiple Sclerosis Journal

published in

1 reference

23 December 2017

volume

11

1 reference

23 December 2017

issue

4

1 reference

23 December 2017

page(s)

420-424

1 reference

23 December 2017

Early onset MS under the age of 16: clinical and paraclinical features

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Multiple sclerosis in childhood: clinical features of 149 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Early onset multiple sclerosis: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Course and prognosis in early-onset MS: comparison with adult-onset forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Prospective study of multiple sclerosis with early onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Disease-modifying therapy in MS: a critical review of the literature. Part I: Analysis of clinical trial errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Early intervention with immunomodulatory agents in the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

A Preliminary Diffusion Tensor and Magnetization Transfer Magnetic Resonance Imaging Study of Early-Onset Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1206OA

10.1191/1352458505MS1206OA

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

16042224

1 reference

23 December 2017